Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market is suffering.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Growth-seeking investors have had a terrible time watching their investments decline on the stock market. Those bullish on long-term prospects for their investments might stick around and hope for the best. Others have cut their losses to invest their money elsewhere. Unfortunately for investors who have faith in cannabis stocks, the situation does not appear to be getting better soon.

The announcement of cannabis legalization for recreational use was a massive game changer for Canadian cannabis producers like Aurora Cannabis (TSX:ACB)(NASDAQ:ACB). The entire cannabis industry has been struck with significant losses in recent weeks. However, Aurora Cannabis leads the downward charge, hitting new all-time lows for the first time since it went public.

What is happening?

Investor sentiment has a massive role to play in the price movements for publicly traded companies on stock markets, and Aurora Cannabis has not given its investors many reasons to be very happy with its performance. The company recently reported a new record of losses in its quarterly earnings.

Aurora Cannabis also sold off facilities crucial to its operations as a cost-cutting measure, making things even worse for the beleaguered cannabis giant. Aurora Cannabis recently agreed to purchase 61.2 million units on a bought deal basis for gross proceeds amounting to US$150 million.

It is a type of financing that makes the investment bank liable to purchase the entire stock offer of the issuing company. The capital-raising tactic is a sound move financially for the company, because it eliminates the risk for Aurora Cannabis. Unfortunately, the move also puts its shareholders at significant risk of dilution.

Aurora Cannabis had 168 million total outstanding shares by the end of 2020. As of March 2022, that number has spiked to 215 million, making its shares worth far less for existing investors. The company’s revenues have been declining for several years, but its outstanding shares keep increasing.

The decision to resort to dilution to finance its operations comes as no surprise after posting a $1 billion loss in its recent quarter. Last year, the same quarter saw a net loss of just $160 million for the company.

Where is the cannabis industry going?

The financial struggles are not limited to Aurora Cannabis alone. The entire cannabis sector has faced issues due to a saturated market exhibiting slow growth. The black market makes matters worse by eating into their top lines. Many consumers still prefer buying from unregulated sources because of more affordable prices.

The industry-specific obstacles have combined with weakness in broader equity markets to weigh heavily on cannabis stocks. Growth stocks are not performing well, and interest rate hikes will make matters worse.

Foolish takeaway

Using cost-cutting measures to improve its chances of turning a profit soon has made Aurora Cannabis a risky bet for its investors. The cannabis industry might see some improvements in the long run as better regulations come into place.

Unfortunately, it could still take several years for Aurora Cannabis and its peers to become profitable. It might be best to avoid allocating capital to buying Aurora Cannabis shares for a long time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Monday, May 30

TSX investors should keep a close eye on the latest manufacturing data from China today.

Read more »